Home > Healthcare & Medical Devices > Proteomics Market
Industry Overview
Proteomics Market size surpassed USD 46.5 billion in 2022 and is poised to depict more than 10% CAGR through 2023-2032, given the escalating investment in cancer proteogenomics.
Government agencies are targeting to gain more insights into the molecular basis of cancer through large-scale proteome and genome analysis. These agencies have also been launching funds for proteomic research to identify cancer-relevant pathways. This program was intended to develop high-throughput, single-cell discovery tools, contributing to the advancement of cancer genomics and proteomics.
Get more details on this report - Request Free Sample PDF
Despite the acceleration of proteomic research, high instrument costs may hinder the industry outlook to a certain extent. Protein structuring involves the use of machines, including X-ray crystallography, and high-throughput fields to conduct protein expression, crystallization, and gene cloning. These processes require several lab hours, resulting in increased costs per sample testing. Additionally, rising costs of instruments may impede clinical proteomic research, especially in developing nations. However, the growing number of death cases due to cancer will promote the development of proteomics platforms, which may contribute to industry development.
| Report Coverage | Details |
|---|---|
| Base Year: | 2022 |
| Market Size in 2022: | 46.5 Billion (USD) |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 10% |
| 2032 Value Projection: | 128 Billion (USD) |
| Historical Data for: | 2018 to 2032 |
| No. of Pages: | 250 |
| Tables, Charts & Figures: | 325 |
| Segments covered: | Component, Technique, Application, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Get more details on this report - Request Free Sample PDF
Expansion of drug development lab operations augments proteomic consumables demand
Proteomics market from the consumables component segment is set to cross USD 83.5 billion by 2032, given the use of kits, strips, and other consumables and reagents in the examination of biological samples. Lab operations and academic institutes have also been expanding over recent years. For instance, in October 2022, Thermo Fisher Scientific Inc. unveiled plans to invest USD 59 million to expand its lab operations in the U.S. to deliver life-changing medicines. Such initiatives will drive the use of proteomic consumables to aid drug discovery.
Bioinformatics analysis to emerge as preferred technique for proteomics research
Get more details on this report - Request Free Sample PDF
Based on the technique, the proteomics market from the bioinformatics analysis segment is poised to depict over 10% CAGR through 2032. Bioinformatics is becoming an integral part of proteomics research, essential for examining protein activity, expression, modifications, and regulations. This technique adopts proteomics algorithms to manage large and varied data during the process of marker discovery. This, alongside the increase in disease outbreaks, will promote the adoption of the bioinformatics technique for proteomics over the forecast period.
Novel biomarker development to boost proteomics implementation in clinical research
Proteomics market from the clinical research application segment is projected to be worth more than USD 69 billion by 2032. The scope of proteomics in clinical research includes the identification of toxicity biomarkers from readily available biological fluids. This approach is also used for target identification & validation, efficacy, and investigations into drug action mechanisms or toxicity. The development of novel biomarkers to improve disease prognosis, diagnosis, and monitoring will therefore enhance the application scope of proteomics in clinical research.
Availability of advanced protein analysis instruments to accelerate proteomics study in labs
In terms of the end-use, the proteomics market share from the laboratories segment will register over 9% CAGR through 2032. The availability of advanced protein analysis techniques and instruments in laboratories is one of the prominent drivers for market growth. Labs also employ multiple quantitative proteomics approaches to optimize deep proteome analysis and post-translational modifications. These activities ensure the production of quality proteomics data, thereby promoting proteomics research in labs and creating lucrative opportunities for industry development.
Investments in life sciences research to fuel adoption of proteomics approach in Europe
Get more details on this report - Request Free Sample PDF
Europe proteomics market is expected to register revenue worth USD 42 billion by 2032, as a result of the mounting government funding in clinical research projects. For example, the EU-funded EPIC-XS project was introduced to bring together prominent proteomics facilities from Europe to support life sciences research in the region. This project was intended to provide access to innovative proteomics facilities, bolstering the implementation of bioinformatics and proteomics approaches in life science research in Europe.
Advanced platform development strategies to define the industry landscape
Key companies operating in the proteomics market include Seer, Inc, Biognosys AG, Creative Proteomics, SomaLogic Operating Co., Inc, Agilent Technologies, Inc, Promega Corporation, Thermo Fisher Scientific, Bruker, Bio-Rad Laboratories, Quantum-Si, Inc, PREOMICS GMBH, and Olink, among others. These companies are focusing on novel platform developments and other strategies to expand their business portfolio in the market.
Impact of COVID-19 Outbreak on proteomics market trends
In wake of the COVID-19 pandemic, several clinical studies were temporarily delayed worldwide due to the implementation of restrictions. However, despite causing disruptions in various sectors, the pandemic created significant demand for proteomics services, asserting a strong impact on market expansion. New trial models or approaches using advanced mass spectrometers for quality outcomes continued to gain momentum, especially among CROs. For instance, in 2020, the deployment of innovative technologies in mass spectrometers allowed the identification of proteins unique to COVID-19. Such attributes have generated favorable growth opportunities for the proteomics industry.
The proteomics market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2032 for the following segments:
By Component
- Instruments
- Consumables
- Services
By Technique
- Advanced technique
- Mass spectrometry
- Gel-based technique
- Protein microarray
- Others
- Conventional technique
- ELISA
- Chromatography based technique
- Edman sequencing
- Western blotting
- Bioinformatics analysis
- Others
By Application
- Clinical diagnosis
- Clinical research
By End-use
- Pharmaceutical & biopharmaceutical companies
- Academic & research institute
- Laboratories
- Others
The above information is provided for the following regions and countries:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Australia
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
- Saudi Arabia
Frequently Asked Questions (FAQ) :